49  Total SME IPOs listed in 2025

2,236.81 Crs.  Total funds raised in 2025

33  SME IPOs listed with Gain in 2025

16  SME IPOs listed with loss in 2025

49  Total SME IPOs listed in 2025

2236.81 Crs.  Total funds raised in 2025

33  SME IPOs listed with Gain in 2025

16  SME IPOs listed with loss in 2025

49  Total SME IPOs listed in 2025

2236.81 Crs.  Total funds raised in 2025

33  SME IPOs listed with Gain in 2025

16  SME IPOs listed with loss in 2025

49  Total SME IPOs listed in 2025

2236.81 Crs.  Total funds raised in 2025

33  SME IPOs listed with Gain in 2025

16  SME IPOs listed with loss in 2025

Remus Pharmaceuticals Limited IPO (Remus Pharmaceuticals IPO) Details

Remus Pharmaceuticals Limited is an Pharmaceutical based company, located in Ahmedabad, Remus Pharmaceuticals Limited IPO size was 47.69 Cr. and was issued at 1229.00 per share. The share of Remus Pharmaceuticals Limited were listed at 1711.00 per share and are currently trading at 2238.95 per share.

Type :
Sub Sector : Marketing And Distribution Pharmaceutical Drugs
SME IPO
NSE EMERGE

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
44.81 Cr.

PAT :
8.59 Cr.

Pricing Report

Issue Price :
1229.00

Listing Price :
1711.00

Current Market Price :
2238.95

Issue Price vs CMP :
1009.95 (82.18%)

listing Price vs CMP :
527.95 (30.86%)

Performance Report (CAGR* wise)

CAGR : 38.65
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.

About Remus Pharmaceuticals

Company Information
Remus Pharmaceuticals is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). They also provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors, regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network, their clients are spread in more than 20 countries. They look forward to form long lasting relationships that enhance the lives of their patients. The Company is majorly engrossed in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical finished formulations and products, manufactured under loan
Show More
Object of Issue
  • To Meet Working Capital Requirements
  • Funding investments for acquisitions and general corporate purposes
  • To meet Public Issue Expenses

Remus Pharmaceuticals SME IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
May, 2023
IPO Size :
47.69 Cr.
Market Cap :
181.03 Cr.   
IPO Subscription :
57.21 X     
PE Multiple :
21.09
IPO Registrar:
Link Intime India Private Limited
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

See Other SME IPOs in Ahmedabad

7NR Retails Limited

  business of trading of apparels in the wholesale and retail segments

  Ahmedabad


A & M Febcon Limited

  business of Industrial equipment and metal fabrication

  Ahmedabad


A and M Jumbo Bags Limited

  engaged in the manufacture and sale of various types of FIBC (Jumbo Bags)

  Ahmedabad


A-1 Acid Limited

  trading of industrial acid and Chemicals.

  Ahmedabad


Aakash Exploration Services Limited

  Oil and Gas Exploration

  Ahmedabad


Peer Companies Of This Sector

FAQs

Remus Pharmaceuticals operates in Pharmaceutical and Marketing And Distribution Pharmaceutical Drugs. The Issue is listed on NSE EMERGE in May, 2023. Remus Pharmaceuticals IPO size was 47.69 Cr. with Issue price of 1229.00 .

Remus Pharmaceuticals IPO subscription was 57.21 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Remus Pharmaceuticals IPO listed at a listing price of 1711.00 against the offer price of 1229.00.

The current market price of Remus Pharmaceuticals is 2238.95.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency